Disease-associated novel CD46 splicing variants and pathologic bone remodeling in otosclerosis

Laryngoscope

Volumn 118, Issue 9, 2008, Pages 1669-1676

  Karosi, Tamás ^a   Szalmás, Anita ^a   Csomor, Péter ^a   Kónya, József ^a   Petkó, Mihaly ^a   Sziklai, István ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Alternative splicing; Bone remodeling; CD46; Measles virus; Otosclerosis

Indexed keywords

CELL RECEPTOR; COMPLEMENTARY DNA; MEMBRANE COFACTOR PROTEIN; NUCLEIC ACID; VIRUS RNA; MESSENGER RNA;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BONE REMODELING; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VIRUS; NUCLEOTIDE SEQUENCE; OTOSCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA SPLICING; SIGNAL TRANSDUCTION; SPLICEOSOME; STAPEDECTOMY; STAPES; VIRUS ATTACHMENT; VIRUS DETECTION; VIRUS REPLICATION; COMPARATIVE STUDY; FOLLOW UP; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; RETROSPECTIVE STUDY; VIROLOGY;

ADULT; AGED; ANTIGENS, CD46; BONE REMODELING; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEASLES; MIDDLE AGED; MORBILLIVIRUS; OTOSCLEROSIS; PROTEIN SPLICING; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAPES;

EID: 51649116682     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e31817c133d     Document Type: Article

References (25)

1. Niedermeyer HP, Arnold W. Otosclerosis: a measles virus associated inflammatory disease. Acta Otolaryngol 1995; 115:300-303.
2. Niedermeyer HP, Arnold W., Schuster M., et al. Persistent measles virus infection and otosclerosis. Ann Otol Rhinol Laryngol 2001;110:897-903.
3. Karosi T., Kónya J., Szabó LZ, Sziklai I. Measles virus prevalence in otosclerotic stapes footplate samples. Otol Neurotol 2004;25:451-456.
4. Chole RA, McKenna MJ. Pathophysiology of otosclerosis. Otol Neurotol 2001;22:249-257.
5. van Den Bogaert K., Govaerts PJ, De Leenheer EM, et al. Otosclerosis: a genetically heterogeneous disease involving at least three different genes. Bone 2002;30:624-630.
6. Linthicum FH Jr. Histopathology of otosclerosis. Otolaryngol Clin North Am 1993;26:335-352.
7. Karosi T., Jókay I., Kónya J., Petkó M., Szabó LZ, Sziklai I. Expression of measles virus receptors in otosclerotic, nonotosclerotic and in normal stapes footplates. Eur Arch Otorhinolaryngol 2007;264:607-613.
8. Lolov SR, Encheva VI, Kyurkchiev SD, Edrev GE, Kehayov IR. Antimeasles immunoglobulin G in sera of patients with otosclerosis is lower than that in healthy people. Otol Neurotol 2001;22:766-770.
9. Karosi T., Kónya J., Petkó M., et al. Antimeasles IgG for serologic diagnosis of otosclerotic hearing loss. Laryngoscope 2006;116:488-493.
10. Erlenhofer C., Duprex WP, Rima BK, ter Meulen V., Schneider-Schaulies J. Analysis of receptor (CD46, CD150) usage by measles virus. J Gen Virol 2002;83:1431-1436.
11. Dhiman N., Jacobson RM, Poland GA. Measles virus receptors: SLAM and CD46. Rev Med Virol 2004;14:217-229.
12. Riley RC, Tannenbaum PL, Abbott DH, Atkinson JP. Cutting edge: inhibiting measles virus infection but promoting reproduction: an explanation for splicing and tissue-specific expression of CD46. J Immunol 2002;169:5405-5409.
13. Schneider-Schaulies J., Dunster LM, Kobune F., Rima B., ter Meulen V. Differential downregulation of CD46 by measles virus strains. J Virol 1995;69:7257-7259.
14. Manchester M., Naniche D., Stehle T. CD46 as a measles receptor: form follows function. Virology 2000;274:5-10.
15. Liszewski MK, Kemper C., Price JD, Atkinson JP. Emerging roles and new functions of CD46. Springer Semin Immunopathol 2005;27:345-358.
16. Riley-Vargas RC, Gill DB, Kemper C., Liszewski MK, Atkinson JP. CD46: expanding beyond complement regulation. Trends Immunol 2004;25:496-503.
17. Zaffran Y., Destaing O., Roux A., et al. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac and extracellular signal-regulated kinase mitogen-activated protein kinase. J Immunol 2001; 167:6780-6785.
18. Astier A., Trescol-Biemont MC, Azocar O., Lamouille B., Rabourdin-Combe C. Cutting edge: CD46, a new costimulatory molecular for T cells that induces pl20CBL and LAT phosphorylation. J Immunol 2000;164:6091-6095.
19. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003;421:388-392.
20. Karp CL, Wysocka M., Wahl LM, et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996;273:228-231.
21. Abdul Ajees A., Gunasekaran K., Volanakis JE, Narayana SV, Kotwal GJ, Murthy HM. The structure of complement C3b provides insights into complement activation and regulation. Nature 2006;444:221-225.
22. Kurita-Taniguchi M., Fukui A., Hazeki K., et al. Functional modulation of human macrophages through CD46 (measles virus receptor) : production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyro sine phosphatase SHP-1 to CD46. J Immunol 2000;165: 5143-5152.
23. Fugier-Vivier I., Servet-Delprat C., Rivailler P., Rissoan MC, Liu YJ, Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997;186: 813-823.
24. Kerdiles YM, Sellin CI, Druelle J., Horvat B. Immunosuppression caused by measles virus: role of viral proteins. Rev Med Virol 2006;16:49-63.
25. Yanagi Y., Takeda M., Ohno S. Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol 2006;87: 2767-2779.